Evozyne
PrivateLast Round
Series B
Sep 27, 2023
Total Funding Raised
$149.18M
Company Overview
Evozyne is a biotechnology company that operates a data-driven molecular engineering platform to develop innovative proteins with enhanced functionalities tailored to meet specific health challenges.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evozyne Comparables
Compare Evozyne with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nabla | 88% | |
| AI Proteins | 86% | |
| Profluent Bio | 85% | |
Evozyne Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 27, 2023 | ||||
| Series A | Apr 21, 2021 | ||||
| Seed | Apr 27, 2020 |
Key People
Founding team and executive leadership
Evozyne Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fidelity Management & Research Company | Series A, Series B |
| OrbiMed | Series B |
| Paragon Biosciences | Seed, Series B, Series A |
| NVentures | Series B |
| Valor Equity Partners | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 27, 2023
$81M round led by Fidelity Management & Research Company and OrbiMed.
- Apr 21, 2021
$54M round with participation from Fidelity and Valor.
Evozyne Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Evozyne's valuation, stock price, and market status.